Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · IEX Real-Time Price · USD
0.695
+0.050 (7.84%)
At close: May 3, 2024, 4:00 PM
0.700
+0.005 (0.72%)
After-hours: May 3, 2024, 7:59 PM EDT
Clover Health Investments Market Cap
Clover Health Investments has a market cap or net worth of $342.99 million as of May 3, 2024. Its market cap has decreased by -1.75% in one year.
Market Cap
342.99M
Enterprise Value
104.97M
1-Year Change
-1.75%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since April 22, 2020, Clover Health Investments's market cap has decreased from $694.80M to $342.99M, a decrease of -50.63%. That is a compound annual growth rate of -16.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 2, 2024 | 319.00M | 0.16% |
May 1, 2024 | 318.50M | 2.08% |
Apr 30, 2024 | 312.00M | -6.53% |
Apr 29, 2024 | 333.80M | -0.89% |
Apr 26, 2024 | 336.80M | 1.51% |
Apr 25, 2024 | 331.80M | 3.08% |
Apr 24, 2024 | 321.90M | 3.17% |
Apr 23, 2024 | 312.00M | 1.27% |
Apr 22, 2024 | 308.10M | -2.19% |
Apr 19, 2024 | 315.00M | 0.80% |
Apr 18, 2024 | 312.50M | 1.43% |
Apr 17, 2024 | 308.10M | -0.48% |
Apr 16, 2024 | 309.60M | -1.71% |
Apr 15, 2024 | 315.00M | -5.06% |
Apr 12, 2024 | 331.80M | -5.90% |
Apr 11, 2024 | 352.60M | -2.35% |
Apr 10, 2024 | 361.10M | -1.07% |
Apr 9, 2024 | 365.00M | 0.94% |
Apr 8, 2024 | 361.60M | 0.42% |
Apr 5, 2024 | 360.10M | -3.69% |
Apr 4, 2024 | 373.90M | -0.27% |
Apr 3, 2024 | 374.90M | 2.71% |
Apr 2, 2024 | 365.00M | -4.30% |
Apr 1, 2024 | 381.40M | -3.03% |
Mar 28, 2024 | 393.30M | 0.13% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tactile Systems Technology | 339.76M |
Sera Prognostics | 338.90M |
Caribou Biosciences | 338.69M |
Nautilus Biotechnology | 335.71M |
Immutep | 333.89M |
Organogenesis Holdings | 331.43M |
Atea Pharmaceuticals | 328.66M |
Kamada | 327.60M |